UnitedHealth Group (NYSE:UNH) Downgraded by Zacks Research to “Hold”

Zacks Research cut shares of UnitedHealth Group (NYSE:UNH) from a strong-buy rating to a hold rating in a research report released on Monday morning,Zacks reports. Zacks Research also issued estimates for UnitedHealth Group’s Q4 2027 earnings at $4.06 EPS.

UNH has been the topic of a number of other reports. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research report on Friday, July 17th. DA Davidson set a $512.00 target price on UnitedHealth Group in a report on Tuesday, July 21st. Piper Sandler set a $477.00 price target on UnitedHealth Group in a report on Thursday, July 16th. Mizuho increased their target price on UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a report on Monday, July 20th. Finally, Oppenheimer lifted their price target on UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $456.56.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $375.95 on Monday. The business has a 50 day simple moving average of $406.84 and a 200 day simple moving average of $369.73. UnitedHealth Group has a one year low of $255.96 and a one year high of $461.62. The company has a market capitalization of $337.46 billion, a PE ratio of 24.19, a price-to-earnings-growth ratio of 1.44 and a beta of 0.61. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. During the same period last year, the business earned $4.08 earnings per share. The business’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, sell-side analysts forecast that UnitedHealth Group will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 59.72%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. Norges Bank bought a new position in shares of UnitedHealth Group in the 4th quarter worth $4,376,167,000. Corient Private Wealth LP bought a new stake in UnitedHealth Group in the second quarter valued at about $245,516,000. Legal & General Group Plc bought a new position in UnitedHealth Group during the second quarter worth about $2,444,928,000. Jupiter Topco LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $2,019,844,000. Finally, BlackRock Inc. raised its position in shares of UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares during the period. 87.86% of the stock is owned by institutional investors.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s raised fiscal 2026 earnings outlook, recent revenue and EPS beats, and stable 86.7% medical loss ratio are supporting the bullish case. Analysts have reportedly increased estimates, while the company’s free-cash-flow yield and valuation may attract long-term investors. UnitedHealth: Lagging, But An Upbeat 2026 Outlook Helps Clear The Path
• Positive Sentiment: UnitedHealth’s use of artificial intelligence across its insurance operations is being highlighted as a potential long-term efficiency and growth driver, reinforcing the company’s competitive positioning. How UnitedHealth Leads the AI Revolution in the Insurance Industry
• Neutral Sentiment: UnitedHealth will report third-quarter 2026 results before the market opens on October 13. The date provides a future catalyst, but does not change current earnings expectations. UnitedHealth Group Announces Earnings Release Date
• Neutral Sentiment: UBS expects UnitedHealth’s earnings-growth outlook to remain broadly intact, although investors continue to focus on Medicare Advantage trends ahead of the next results. UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says
• Negative Sentiment: UnitedHealth is selling an interest in underperforming WellMed clinics in Florida to TPG, citing the need for local operating expertise rather than cash. The transaction underscores cost pressures, restrictive Medicare Advantage payments, and the operational reset at Optum Health—issues that are weighing on near-term sentiment. UnitedHealth Partners with TPG to Strengthen Underperforming Florida Clinics
• Negative Sentiment: The September 14 ex-dividend date may create short-term technical pressure, though shareholders of record remain eligible for the $2.32-per-share cash dividend payable September 22. UnitedHealth Group Dividend Analysis

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.